|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Research and development expenses | |||||
| Restructuring, net | |||||
| Acquisition related expenses | |||||
| Asbestos adjustments | |||||
| Operating income | |||||
| Interest, net | |||||
| Other expense (income), net | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Net income | |||||
| Cash flow hedges | |||||
| Pension adjustments | |||||
| Currency translation adjustments | |||||
| Reclassification of other comprehensive income | |||||
| Comprehensive income | |||||
| Income per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average common shares outstanding (Millions): | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...
